GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Q

Qomel 9600.SR · SAR

N/A · Tadawul · 🇸🇦 Saudi Arabia

Compare

34.00

+11.48%

Close of 5 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Qomel

Its shares trade on Tadawul under the ticker 9600.SR. It has been listed since 9 May 2024. In the fiscal year to 31 December 2025, it reported revenue of SAR 132.2m and net income of SAR 15.0m. At that date it held total assets of SAR 218.6m and shareholders' equity of SAR 119.9m.

Qomel Co is a SA-based company operating in industry. The company is headquartered in Riyadh, Riyadh. The company went IPO on 2024-05-09. Qomel Company is a Saudi Arabia-based entity which primarily engaged in providing health care services. The firm is also engaged in pharmaceutical preparations manufacturing. The firm's services include general medical services and specialized services, medicines and medical services to patients, diagnostic services, and medical equipment, and materials supplies. The firm has branches in Jeddah, along the Red Sea, and Dammam, at the Arabian Gulf.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
N/A
Industry
N/A
Listed since
9 May 2024
Website
qomel.com ↗

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Riyadh, Saudi Arabia
  • Operates in healthcare services and pharmaceutical manufacturing
  • Has branches in Jeddah and Dammam

Weaknesses

  • Sector and industry information not specified
  • IPO date is 2024-05-09, indicating a new market presence
  • Source description is untrusted and contains conflicting information

Opportunities

  • Expanding healthcare services in Saudi Arabia
  • Growing demand for pharmaceutical manufacturing in the region
  • Potential for branch expansion to other cities

Threats

  • Untrusted source description may lead to misinformation
  • New IPO may face market volatility
  • Lack of specified sector and industry could hinder strategic planning

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.